[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Report 2017

September 2017 | 107 pages | ID: G6BE1E4557CEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global API(Active Pharmaceutical Ingredient) Intermediate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of API(Active Pharmaceutical Ingredient) Intermediate for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global API(Active Pharmaceutical Ingredient) Intermediate market competition by top manufacturers/players, with API(Active Pharmaceutical Ingredient) Intermediate sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Jigs Chemical
  • Sanofi Winthrop Industrie S.A.
  • Shandong Jiulong Fine Chemical Co., Ltd.
  • Hipharma Limited
  • AMPAC Fine Chemicals
  • BASF
  • Cambrex Corporation
  • A R Life Sciences Pvt. Ltd.
  • Dragon Hwa ChemPharm. Co., Ltd.
  • Ami Life Sciences Pvt. Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • By Product
    • Biotech Intermediates
    • Chemical Intermediates
  • By Type of Intermediate
    • Patent Intermediates
    • Non-patent Intermediates
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of API(Active Pharmaceutical Ingredient) Intermediate for each application, including
  • Oncology
  • Diabetes
  • Endocrinology
  • Cardiovascular Disease
  • CNS & Neurological Disorders
If you have any special requirements, please let us know and we will offer you the report as you want.
Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Report 2017

1 API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MARKET OVERVIEW

1.1 Product Overview and Scope of API(Active Pharmaceutical Ingredient) Intermediate
1.2 Classification of API(Active Pharmaceutical Ingredient) Intermediate by Product Category
  1.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Biotech Intermediates
  1.2.4 Chemical Intermediates
1.3 Global API(Active Pharmaceutical Ingredient) Intermediate Market by Application/End Users
  1.3.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Oncology
  1.3.3 Diabetes
  1.3.4 Endocrinology
  1.3.5 Cardiovascular Disease
  1.3.6 CNS & Neurological Disorders
1.4 Global API(Active Pharmaceutical Ingredient) Intermediate Market by Region
  1.4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
  1.4.3 China API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
  1.4.4 Europe API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
  1.4.5 Japan API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
  1.4.6 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
  1.4.7 India API(Active Pharmaceutical Ingredient) Intermediate Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of API(Active Pharmaceutical Ingredient) Intermediate (2012-2022)
  1.5.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2022)
  1.5.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2022)

2 GLOBAL API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Competition by Players/Suppliers
  2.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global API(Active Pharmaceutical Ingredient) Intermediate (Volume and Value) by Type
  2.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Type (2012-2017)
  2.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Type (2012-2017)
2.3 Global API(Active Pharmaceutical Ingredient) Intermediate (Volume and Value) by Region
  2.3.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales and Market Share by Region (2012-2017)
  2.3.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Region (2012-2017)
2.4 Global API(Active Pharmaceutical Ingredient) Intermediate (Volume) by Application

3 UNITED STATES API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE (VOLUME, VALUE AND SALES PRICE)

3.1 United States API(Active Pharmaceutical Ingredient) Intermediate Sales and Value (2012-2017)
  3.1.1 United States API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  3.1.2 United States API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2017)
  3.1.3 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Price Trend (2012-2017)
3.2 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Players
3.3 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Type
3.4 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Application

4 CHINA API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE (VOLUME, VALUE AND SALES PRICE)

4.1 China API(Active Pharmaceutical Ingredient) Intermediate Sales and Value (2012-2017)
  4.1.1 China API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  4.1.2 China API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2017)
  4.1.3 China API(Active Pharmaceutical Ingredient) Intermediate Sales Price Trend (2012-2017)
4.2 China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Players
4.3 China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Type
4.4 China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Application

5 EUROPE API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE (VOLUME, VALUE AND SALES PRICE)

5.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales and Value (2012-2017)
  5.1.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  5.1.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2017)
  5.1.3 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Price Trend (2012-2017)
5.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Players
5.3 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Type
5.4 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Application

6 JAPAN API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE (VOLUME, VALUE AND SALES PRICE)

6.1 Japan API(Active Pharmaceutical Ingredient) Intermediate Sales and Value (2012-2017)
  6.1.1 Japan API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  6.1.2 Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2017)
  6.1.3 Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Price Trend (2012-2017)
6.2 Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Players
6.3 Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Type
6.4 Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Application

7 SOUTHEAST ASIA API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales and Value (2012-2017)
  7.1.1 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Price Trend (2012-2017)
7.2 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Players
7.3 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Type
7.4 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Application

8 INDIA API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE (VOLUME, VALUE AND SALES PRICE)

8.1 India API(Active Pharmaceutical Ingredient) Intermediate Sales and Value (2012-2017)
  8.1.1 India API(Active Pharmaceutical Ingredient) Intermediate Sales and Growth Rate (2012-2017)
  8.1.2 India API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate (2012-2017)
  8.1.3 India API(Active Pharmaceutical Ingredient) Intermediate Sales Price Trend (2012-2017)
8.2 India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Players
8.3 India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Type
8.4 India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Market Share by Application

9 GLOBAL API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Jigs Chemical
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Sanofi Winthrop Industrie S.A.
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Shandong Jiulong Fine Chemical Co., Ltd.
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Hipharma Limited
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 AMPAC Fine Chemicals
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 BASF
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 BASF API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Cambrex Corporation
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 A R Life Sciences Pvt. Ltd.
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Dragon Hwa ChemPharm. Co., Ltd.
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Ami Life Sciences Pvt. Ltd.
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview

10 API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MAUFACTURING COST ANALYSIS

10.1 API(Active Pharmaceutical Ingredient) Intermediate Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate
10.3 Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of API(Active Pharmaceutical Ingredient) Intermediate Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MARKET FORECAST (2017-2022)

14.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price and Trend Forecast (2017-2022)
14.2 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Type (2017-2022)
  14.3.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Type (2017-2022)
  14.3.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price Forecast by Type (2017-2022)
14.4 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of API(Active Pharmaceutical Ingredient) Intermediate
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Comparison (K MT) by Type (2012-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type (Product Category) in 2016
Figure Biotech Intermediates Product Picture
Figure Chemical Intermediates Product Picture
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Comparison (K MT) by Application (2012-2022)
Figure Global Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Endocrinology Examples
Table Key Downstream Customer in Endocrinology
Figure Cardiovascular Disease Examples
Table Key Downstream Customer in Cardiovascular Disease
Figure CNS & Neurological Disorders Examples
Table Key Downstream Customer in CNS & Neurological Disorders
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Market Size (Million USD) by Regions (2012-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) and Growth Rate (2012-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) of Key Players/Suppliers (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Players/Suppliers (2012-2017)
Figure 2016 API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Players/Suppliers
Figure 2017 API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Players/Suppliers
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Players
Table 2017 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Players
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Market Share by Type (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share (K MT) by Type (2012-2017)
Figure Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate by Type (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Type (2012-2017)
Figure Revenue Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate by Type (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) and Market Share by Region (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Region (2012-2017)
Figure Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Region (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate by Region in 2016
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Region (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate by Region in 2016
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Region (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region in 2016
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) and Market Share by Application (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Application (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Price (USD/MT) Trend (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Players (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players in 2016
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Type (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type in 2016
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Application (2012-2017)
Table United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application (2012-2017)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application in 2016
Figure China API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2017)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Sales Price (USD/MT) Trend (2012-2017)
Table China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Players (2012-2017)
Table China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players (2012-2017)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players in 2016
Table China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Type (2012-2017)
Table China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type (2012-2017)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type in 2016
Table China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Application (2012-2017)
Table China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application (2012-2017)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application in 2016
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Price (USD/MT) Trend (2012-2017)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Players (2012-2017)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players in 2016
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Type (2012-2017)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type in 2016
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Application (2012-2017)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application (2012-2017)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application in 2016
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Price (USD/MT) Trend (2012-2017)
Table Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Players (2012-2017)
Table Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players (2012-2017)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players in 2016
Table Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Type (2012-2017)
Table Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type (2012-2017)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type in 2016
Table Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Application (2012-2017)
Table Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application (2012-2017)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application in 2016
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Players (2012-2017)
Table Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players in 2016
Table Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Type (2012-2017)
Table Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type in 2016
Table Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Application (2012-2017)
Table Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application in 2016
Figure India API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate (2012-2017)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2017)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Sales Price (USD/MT) Trend (2012-2017)
Table India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Players (2012-2017)
Table India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players (2012-2017)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Players in 2016
Table India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Type (2012-2017)
Table India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type (2012-2017)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Type in 2016
Table India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) by Application (2012-2017)
Table India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application (2012-2017)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share by Application in 2016
Table Jigs Chemical Basic Information List
Table Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales Global Market Share (2012-2017
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Revenue Global Market Share (2012-2017)
Table Sanofi Winthrop Industrie S.A. Basic Information List
Table Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales Global Market Share (2012-2017
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Revenue Global Market Share (2012-2017)
Table Shandong Jiulong Fine Chemical Co., Ltd. Basic Information List
Table Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Global Market Share (2012-2017
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Global Market Share (2012-2017)
Table Hipharma Limited Basic Information List
Table Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales Global Market Share (2012-2017
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Revenue Global Market Share (2012-2017)
Table AMPAC Fine Chemicals Basic Information List
Table AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales Global Market Share (2012-2017
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Revenue Global Market Share (2012-2017)
Table BASF Basic Information List
Table BASF API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Sales Global Market Share (2012-2017
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Revenue Global Market Share (2012-2017)
Table Cambrex Corporation Basic Information List
Table Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales Global Market Share (2012-2017
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Revenue Global Market Share (2012-2017)
Table A R Life Sciences Pvt. Ltd. Basic Information List
Table A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Global Market Share (2012-2017
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Global Market Share (2012-2017)
Table Dragon Hwa ChemPharm. Co., Ltd. Basic Information List
Table Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Global Market Share (2012-2017
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Global Market Share (2012-2017)
Table Ami Life Sciences Pvt. Ltd. Basic Information List
Table Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2012-2017)
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales Global Market Share (2012-2017
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of API(Active Pharmaceutical Ingredient) Intermediate
Figure Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate
Figure API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis
Table Raw Materials Sources of API(Active Pharmaceutical Ingredient) Intermediate Major Players in 2016
Table Major Buyers of API(Active Pharmaceutical Ingredient) Intermediate
Table Distributors/Traders List
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Price (USD/MT) and Trend Forecast (2017-2022)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) Forecast by Regions (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share Forecast by Regions in 2022
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Regions (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Regions in 2022
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate Forecast (2017-2022)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Type (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Volume Market Share Forecast by Type (2017-2022)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Type (2017-2022)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Price (USD/MT) Forecast by Type (2017-2022)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Application (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications